Indium (111in) Dtpa Curium Netherlands B.V.

Indium-111 pentetate, the active ingredient in Indium (111in) Dtpa Curium Netherlands B.V., is a radiopharmaceutical presented as a sterile solution for intrathecal use. It enables visualization of cerebrospinal fluid pathways and assists in detecting CSF leaks in diagnostic imaging procedures.

GNH USA supplies Indium (111in) Dtpa Curium Netherlands B.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Customers receive reliable logistics and technical support for radiopharmaceutical handling.

Indium-111 pentetate is used in diagnostic imaging of the cerebrospinal fluid system.

Cerebrospinal fluid (CSF) imaging: visualizes CSF flow pathways and ventricular anatomy. Detection of CSF leaks: identifies spinal or cranial cerebrospinal fluid leaks. Intrathecal radionuclide cisternography: provides functional assessment of CSF circulation after intrathecal administration.

Adverse reactions to Indium-111 pentetate are generally related to the intrathecal route and the radioisotope exposure.

Common Side Effects: - Headache: mild to moderate headache following injection. - Nausea: transient nausea or upset stomach. - Injection site discomfort: mild pain or irritation at the injection site.

Serious or Rare Side Effects: - Allergic reaction: anaphylaxis or severe hypersensitivity. - Severe headache: persistent or worsening headache indicating increased intracranial pressure. - Radiation‑induced myelosuppression: bone‑marrow suppression with prolonged exposure.

When using Indium-111 pentetate, specific safety measures should be observed. - Pregnancy: avoid unless diagnostic benefit outweighs risk; limited data on fetal exposure. - Breastfeeding: discontinue breastfeeding or ensure an adequate interval after administration. - Concomitant intrathecal agents: avoid simultaneous use of other intrathecal drugs to prevent chemical incompatibility. - Renal impairment: assess renal function as clearance of chelated indium may be reduced. - Radiation safety: follow radiation protection guidelines for staff and patient. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Indium-111 pentetate may interact with certain agents; monitoring is required.

Major Interactions (Avoid): - Other radiopharmaceuticals: concurrent administration may cause overlapping radiation fields. - Iodinated contrast agents: may interfere with imaging interpretation. - Intrathecal antibiotics or steroids: risk of chemical incompatibility.

Moderate Interactions (Monitor Closely): - Anticoagulants: monitor for bleeding at injection site. - Diuretics: may alter CSF dynamics affecting distribution. - CNS depressants: observe for additive sedation.